TABLE 4.

Observed anthropometric parameters and blood lipids in 18 subjects measured during the 9-wk study, including a 1-wk washout and an 8-wk consumption period^*

Parameter	t = −1 wk	t = 0 wk	t = 4 wk	t = 8 wk
Weight (kg)	78.9 ± 19.1A†	78.9 ± 19.0A	78.8 ± 19.1A	79.4 ± 19.5A
Pulse (beats/min)	67.2 ± 10.7A	67.2 ± 10.8A	68.5 ± 11.6A	67.4 ± 10.7 A
Blood pressure
Systole (mmHg)	112.7 ± 14.4A	116.7 ± 12.6A	115.8 ± 12.3A	115.5 ± 10.9A
Diastole (mmHg)	72.5 ± 8.8A	69.4 ± 10.0AB	66.9 ± 8.8B	69.3 ± 7.9AB
Triacylglycerols (mg/dL)‡	110.3 ± 57.4A	104.2 ± 57.5A	110.1 ± 70.6A	102.8 ± 55.2A
Total-C§ (mg/dL)	181.0 ± 30.9A	163.9 ± 23.6B	176.7 ± 30.2A	175.7 ± 30.9AB
LDL-C (mg/dL)	111.6 ± 27.0A	100.8 ± 25.3B	106.2 ± 25.9AB	103.5 ± 26.6AB
HDL-C (mg/dL)	47.3 ± 15.8A	43.1 ± 15.9B	48.3 ± 13.6AC	51.7 ± 14.9C
Total-C/HDL-C	4.25 ± 1.59A	4.35 ± 1.86A	3.93 ± 1.31AB	3.63 ± 1.16B
VLDL+LDL-C (mg/dL)	126.8 ± 33.7A	nm$	111.8 ± 34.9AB	110.5 ± 33.4B
C-reactive protein (mg/L)	2.17 ± .2.18A	nm	1.85 ± 2.11A	2.60 ± 3.53A
Cu2+-mediated oxidation of LDL+VLDL-C (min)	138.5 ± 18.2A	nm	145.0 ± 19.3AB	146.3 ± 14.7B
Apolipoprotein A–I (mg/dL)	154.9 ± 38.1A	nm	nm	148.6 ± 45.9A
Apolipoprotein B (mg/dL)	76.6 ± 16.4A	nm	nm	71.8 ± 17.2A
8-iso-PGF2α (ng/mg creatinine)*	0.359 ± 0.303A	nm	0.387 ± 0.414A	0.405 ± 0.324A
PLAC|| (nmol/L)	25.4 ± 11.5A	nm	22.6 ± 10.1A	22.7 ± 7.0A
PWAC** (nmol/L)	200.1 ± 54.0A	nm	200.4 ± 55.8A	199.3 ± 54.7A

^*Including 294 mL soy-fortified tomato juice/d containing 242 μmol isoflavones and 40 μmol lycopene. All values given as mean ± SD.

^†Values in a row not sharing the same superscript are statistically significant different (P < 0.05, Tukey’s).

^‡Triacylglycerols.

^§C = plasma cholesterol.

^||Plasma antioxidant capacity in lipid extract in trolox equivalent units.

^**Plasma antioxidant capacity in total plasma in ascorbic acid equivalent units.

^$nm indicates not measured due to limited amount of blood plasma or resources.